
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Kirsi J. Rautajoki, Serafiina Jaatinen, Anja Hartewig, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Kirsi J. Rautajoki, Serafiina Jaatinen, Anja Hartewig, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription
Francesca Pagani, Francesca Orzan, Sara Lago, et al.
Acta Neuropathologica (2025) Vol. 149, Iss. 1
Closed Access
Francesca Pagani, Francesca Orzan, Sara Lago, et al.
Acta Neuropathologica (2025) Vol. 149, Iss. 1
Closed Access
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival
Eduardo Rodriguez Almaraz, Geno Guerra, Nadeem Al-Adli, et al.
Neuro-Oncology Advances (2025) Vol. 7, Iss. 1
Open Access
Eduardo Rodriguez Almaraz, Geno Guerra, Nadeem Al-Adli, et al.
Neuro-Oncology Advances (2025) Vol. 7, Iss. 1
Open Access
Pyrosequencing Analysis of O-6-Methylguanine-DNA Methyltransferase Methylation at Different Cut-Offs of Positivity Associated with Treatment Response and Disease-Specific Survival in Isocitrate Dehydrogenase-Wildtype Grade 4 Glioblastoma
Fábio França Vieira e Silva, Marina Di Domenico, Vito Carlo Alberto Caponio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 612-612
Open Access | Times Cited: 2
Fábio França Vieira e Silva, Marina Di Domenico, Vito Carlo Alberto Caponio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 612-612
Open Access | Times Cited: 2
Enhancing glioma care with advanced imaging: T2-FLAIR mismatch as a predictive biomarker in IDH-mutant astrocytoma
Manal Nadeem, Umer Bin Shahzad, Naz Hawre Tahir, et al.
Neurosurgical Review (2024) Vol. 47, Iss. 1
Closed Access | Times Cited: 1
Manal Nadeem, Umer Bin Shahzad, Naz Hawre Tahir, et al.
Neurosurgical Review (2024) Vol. 47, Iss. 1
Closed Access | Times Cited: 1
CDKN2A Homozygous Deletion Is a Stronger Predictor of Outcome than IDH1/2-Mutation in CNS WHO Grade 4 Gliomas
Sang Hyuk Lee, Tae Gyu Kim, Kyeong Hwa Ryu, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2256-2256
Open Access | Times Cited: 1
Sang Hyuk Lee, Tae Gyu Kim, Kyeong Hwa Ryu, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2256-2256
Open Access | Times Cited: 1
Progress in Research on Flavonoids in Inhibiting Glioblastoma by Regulating Tumor Microenvironment
人立 陈
Advances in Clinical Medicine (2024) Vol. 14, Iss. 10, pp. 391-397
Closed Access
人立 陈
Advances in Clinical Medicine (2024) Vol. 14, Iss. 10, pp. 391-397
Closed Access
IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
Kristian A. Choate, Evan P.S. Pratt, Matthew J. Jennings, et al.
Biology (2024) Vol. 13, Iss. 11, pp. 885-885
Open Access
Kristian A. Choate, Evan P.S. Pratt, Matthew J. Jennings, et al.
Biology (2024) Vol. 13, Iss. 11, pp. 885-885
Open Access